BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 26775592)

  • 41. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer.
    Miller DA; Krasna MJ
    Surg Oncol Clin N Am; 2016 Jul; 25(3):611-20. PubMed ID: 27261919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The feasibility and efficacy of stereotactic body radiotherapy for centrally-located lung tumors.
    Takahashi W; Yamashita H; Omori M; Kitaguchi M; Shibata-Kobayashi S; Sakumi A; Nakagawa K
    Anticancer Res; 2013 Nov; 33(11):4959-64. PubMed ID: 24222136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic body radiation therapy for stage I non-small cell lung cancer.
    Chang JY; Roth JA
    Thorac Surg Clin; 2007 May; 17(2):251-9. PubMed ID: 17626403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
    Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
    Neri S; Takahashi Y; Terashi T; Hamakawa H; Tomii K; Katakami N; Kokubo M
    J Thorac Oncol; 2010 Dec; 5(12):2003-7. PubMed ID: 21102262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.
    Kong DS; Lee JI; Nam DH; Park K; Kim JH; Kim JG; Park JO; Park K
    J Korean Med Sci; 2006 Jun; 21(3):527-32. PubMed ID: 16778400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereotactic body radiotherapy for oligometastatic disease.
    Hanna GG; Landau D
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
    Parks J; Kloecker G; Woo S; Dunlap NE
    Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.
    Pasqualetti F; Panichi M; Sainato A; Matteucci F; Galli L; Cocuzza P; Ferrazza P; Coraggio G; Pasqualetti G; Derosa L; Sollini M; Mannelli L; Ortori S; Monzani F; Ricci S; Greco C; Fabrini MG; Erba PA
    Radiat Oncol; 2016 Jan; 11():9. PubMed ID: 26796633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of initial treatment only by linac-based stereotactic radiosurgery for a metastatic brain tumor from non-small cell lung cancer].
    Nagai M; Oguma H; Arai F; Watanabe E; Nakazawa M
    No Shinkei Geka; 2014 Apr; 42(4):327-34. PubMed ID: 24698893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
    Hearn JW; Videtic GM; Djemil T; Stephans KL
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer.
    Matsuo Y; Shibuya K; Nagata Y; Norihisa Y; Narabayashi M; Sakanaka K; Ueki N; Mizowaki T; Hiraoka M
    J Thorac Oncol; 2012 Feb; 7(2):453-6. PubMed ID: 22252562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions.
    Lang P; Gomez DR; Palma DA
    Semin Respir Crit Care Med; 2020 Jun; 41(3):369-376. PubMed ID: 32450591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy.
    Atallah S; Cho BC; Allibhai Z; Taremi M; Giuliani M; Le LW; Brade A; Sun A; Bezjak A; Hope AJ
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):532-8. PubMed ID: 24929163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial.
    Bassetti MF; Morris BA; Sethakorn N; Lang JM; Schehr JL; Zhao SG; Morris ZS; Buehler D; Eickhoff JC; Harari PM; Traynor AM; Campbell TC; Baschnagel AM; Leal TA
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1481-1489. PubMed ID: 38072321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience.
    Lindberg K; Nyman J; Riesenfeld Källskog V; Hoyer M; Lund JÅ; Lax I; Wersäll P; Karlsson K; Friesland S; Lewensohn R
    Acta Oncol; 2015; 54(8):1096-104. PubMed ID: 25813471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
    Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease.
    Bhattacharya IS; Woolf DK; Hughes RJ; Shah N; Harrison M; Ostler PJ; Hoskin PJ
    Br J Radiol; 2015 Apr; 88(1048):20140712. PubMed ID: 25679321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.